APA (7th ed.) Citation

Y, C., QP, L., SJ, Y., J, D., XY, L., & H, X. (2026). Opportunities and challenges in the development of evolving EGFR inhibitors to overcome EGFR TKIs resistance. Acta pharmacologica Sinica. https://doi.org/10.1038/s41401-026-01855-0

Chicago Style (17th ed.) Citation

Y, Chen, Liu QP, Yang SJ, Ding J, Lu XY, and Xie H. "Opportunities and Challenges in the Development of Evolving EGFR Inhibitors to Overcome EGFR TKIs Resistance." Acta Pharmacologica Sinica 2026. https://doi.org/10.1038/s41401-026-01855-0.

MLA (9th ed.) Citation

Y, Chen, et al. "Opportunities and Challenges in the Development of Evolving EGFR Inhibitors to Overcome EGFR TKIs Resistance." Acta Pharmacologica Sinica, 2026, https://doi.org/10.1038/s41401-026-01855-0.